carbamazepine pharmaquick®, 200 mg, comprimé / tablet, b/100x10
pharmaquick - la carbamazÉpine - comprimé / tablet - 200 mg
ciprofloxacine pharmaquick, 500 mg, comprimé / tablet, b/10x10
pharmaquick - ciprofloxacine - comprimé / tablet - 500 mg
hydrochlorothiazide pharmaquick®, 50 mg, comprimé / tablet, b/20
pharmaquick - hydrochlorothiazide - comprimé / tablet - 50 mg
nystatin pharmaquick, 500 000 ui, comprimé / tablet, b/100x10
pharmaquick - la nystatine - comprimé / tablet - 500 000 ui
permanagnate de potasium pharmaquick, 500 mg, comprimé / tablet, b/1000 vrac
pharmaquick - permanganate de potassium - comprimé / tablet - 500 mg
quinine sulfate pharmaquick, 300 mg, comprimé / tablet, b/ 50x10 sous blisters
pharmaquick - la quinine - comprimé / tablet - 300 mg
alpha ject micro 1 noda emulsion injectable pour bar
pharmaq - virus de la nécrose nerveuse virale - emulsion injectable
alpha ject micro 2000 emulsion injectable pour bar
pharmaq - listonella anguillarum, photobacterium damsela - emulsion injectable
romet 30 premix prémélange médicamenteux
pharmaq as - sulfadiméthoxine; ormétoprime - prémélange médicamenteux - 250g; 50g - sulfadiméthoxine 250g; ormétoprime 50g - poisson À nageoires
teriparatide sun
sun pharmaceutical industries europe b.v. - tériparatide - osteoporosis; osteoporosis, postmenopausal - homéostasie du calcium - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.